Classification
Product TypeProcessed Food
Product FormDietary supplement (tablets, including effervescent tablets)
Industry PositionFinished consumer nutraceutical / borderline product (regulatory classification depends on claims)
Market
Calcium supplements in Sri Lanka are primarily a consumer nutraceutical category sold through pharmacy retail and online pharmacy channels. Regulatory treatment depends on product presentation and claims: products evaluated as “borderline products” (combining characteristics of medicines and foods) are subject to NMRA registration and related controls. NMRA has linked approvals and document submission for medicines/medical devices/borderline products to Sri Lanka Customs’ ASYCUDA single-window clearance, increasing the risk of border delays for unregistered or mis-documented consignments. Food labelling rules apply to packaged products, and Sri Lanka has issued updated food labelling regulations scheduled to come into operation on 1 July 2026.
Market RoleImport-dependent consumer market (net importer)
Domestic RoleRetail consumer health product category distributed mainly via pharmacies and online pharmacy/e-commerce
Specification
Primary VarietyCalcium carbonate (common calcium source in tablet formulations)
Physical Attributes- Swallow tablets
- Effervescent tablets (dissolved in water)
Compositional Metrics- Example in-market label claim: 500 mg of calcium per effervescent tablet (with vitamin D3) is stated for at least one product sold via Sri Lanka pharmacy retail.
Supply Chain
Value Chain- Overseas manufacturer → Sri Lankan marketing authorization holder / local agent → shipment → Sri Lanka Customs import declaration in ASYCUDA → NMRA single-window document upload/approval (as applicable) → importer/distributor → retail pharmacies and online pharmacy retailers
Temperature- Typically ambient-stable finished dosage forms; humidity protection is important for tablet/effervescent integrity during storage and distribution.
Freight IntensityLow
Transport ModeSea
Risks
Regulatory Compliance HighConsignments of calcium supplements that are classified as NMRA “borderline products” can face severe customs clearance disruption if NMRA registration/classification and required document uploads are not in place under the ASYCUDA single-window process; NMRA has explicitly described goods accumulating at Customs when importers could not clear products due to missing registration.Obtain NMRA product classification (preliminary evaluation) and proceed to registration as required before shipment; ensure the local agent/MAH uploads complete documentation in the ASYCUDA format and keeps labels/claims aligned with the approved dossier.
Documentation MediumIncomplete or non-compliant registration documentation (e.g., free sale certificate/COPP, acceptable finished-product CoA, label artwork, formula documentation) can lead to NMRA application rejection and/or border delays.Run a pre-submission dossier checklist against NMRA borderline product requirements and confirm certificates are issued by acceptable authorities and are properly addressed where required.
Labeling And Claims MediumLabel statements and promotional claims can trigger enforcement action and delays: NMRA indicates advertising approval is required for borderline products and warns that misleading/incorrect information is an offence; food labelling requirements are also evolving with Food (Labelling and Advertising) Regulations 2026 scheduled for 1 July 2026.Perform regulatory review of label and marketing claims for Sri Lanka before printing; maintain an approval file for NMRA advertising permissions where applicable and monitor the 2026 labelling transition timeline for products manufactured from 1 July 2026.
Product Quality MediumQuality non-conformance can block market access: NMRA borderline product applications reference submission of an acceptable finished-product certificate of analysis, and NMRA maintains a medicines quality assurance laboratory function for analysis of regulated products.Use qualified manufacturers with documented GMP controls; retain lot-specific CoAs and, where needed, arrange pre-shipment or post-arrival testing plans aligned to Sri Lanka requirements.
Labor & Social- Misleading health claims and non-compliant promotion are enforcement risks: NMRA indicates prior written approval is required for advertising/promotions of borderline products, and misleading/incorrect information can be punishable.
Standards- GMP evidence (e.g., GMP certificates / site approval documentation used in NMRA processes)
- Finished-product Certificate of Analysis (CoA) (commonly required in NMRA borderline product applications)
FAQ
Are calcium supplements treated as medicines or foods in Sri Lanka?It depends on how the product is classified based on intended use, mode of action, and claims. NMRA defines and regulates “borderline products” as products with combined characteristics of medicines and foods/cosmetics/devices, and states that products falling under this category should be registered with NMRA through a local agent; NMRA also notes that nutraceuticals with therapeutic claims fall under the medicine definition in its medicines regulatory overview.
What documents are commonly expected for NMRA borderline product classification/registration for vitamin/mineral supplements?NMRA’s borderline product guidance lists dossier elements such as a covering letter and manufacturer authorization for the local agent, product master formula and batch manufacturing formula, a free sale certificate or COPP (as applicable), an acceptable finished-product certificate of analysis, label/packaging specimens, and product information leaflet/pack insert (plus promotional materials if applicable).
How does ASYCUDA affect importing calcium supplements into Sri Lanka?Sri Lanka Customs requires import declarations to be submitted online in ASYCUDA, and NMRA states that customs clearance for medicines/medical devices/borderline products/cosmetics is facilitated through ASYCUDA with document upload requirements for consignees after 19 September 2024. NMRA has also reported that products can accumulate at Customs when importers cannot clear borderline-category consignments due to missing NMRA registration/classification.
Is Sri Lanka changing food labelling rules in 2026, and does that matter for supplements?Sri Lanka’s Ministry of Health food control program has issued Food (Labelling and Advertising) Regulations 2026 scheduled to come into operation on 1 July 2026 (with stated non-application to products manufactured before that date). If a calcium supplement is regulated as a food product for labelling purposes, importers should check whether the 2026 labelling rules apply based on the product’s manufacturing date and packaging/label status.